MLTC-M Community of Practice in Clinical Context and Pathways (Clinical Community of Practice)

人们倾向于积累健康问题和诊断。当几种长期的健康问题或诊断同时存在时，称为多发病。我们的研究是由战略优先基金资助的，因为多发病现在在英国和全世界都被认为是一个巨大的问题。传统上，临床研究集中在一种健康状况上，通常有几种诊断或多种疾病的人被排除在研究研究之外。我们正在申请资金，以便在多病研究小组之间开展合作。我们的目标是为从事多病研究的临床医生(医生、护士、药剂师、理疗师或任何临床背景的医生)创建一个实践社区。这个临床实践社区(COP)将为不同研究小组的临床医生提供一个机会，让他们见面、学习、分享想法和提出新想法，以形成未来的研究。临床COP将集中在一个在线平台上，在这个平台上，我们可以相互互动，形成具有特定重点的小组。例如，一些健康问题可以毫无疑问地被诊断出来--如心脏病发作或中风--而其他健康问题则更难定义，如精神健康状况、疼痛或大小便失禁。更复杂的是将不同的健康问题联系在一起。这些较小的组织可能会专注于这些复杂的领域。我们将开展面对面的发布会活动，共同努力确定优先事项--我们希望确保我们有效合作，克服最大的挑战。之后，我们将在在线平台(我们希望通过国家卫生研究所(NIHR)与其他多病临床研究人员共同开发)、社交媒体上通过特定的标签和每月时事通讯与我们的成员进行交流。我们的核心调查小组将每3个月举行一次会议。将举办6个关于关键主题的虚拟讲习班。我们将确保我们与其他资助的COP进行对话，看看我们是否可以在特定主题上合作，将我们的临床技能与他们的技能结合起来：例如，通过拟议的统计方法COP和患者和公众的参与和参与。我们将通过我们的网络进行一项调查，试图了解临床医生认为多病研究的关键优先事项是什么，我们将撰写这项研究并发表，这可能会导致这一领域的其他工作。COP将支持这项多病研究与临床医生的沟通，并有助于增加多病研究和研究交付能力。我们将主办研讨会，并已获得初级保健和老年医学的主要合作伙伴原则上同意在他们的会议上介绍COP研究。我们还将在COP拨款结束时举办一场活动，作为向更广泛的临床观众和其他感兴趣的人展示临床的机会。临床COP支持多发病工作的另一个关键方法是考虑这项研究的下一步，以及我们如何才能使患者受益。我们预计，这将是一个工作组、一个虚拟研讨会和一个写作小组的重点，以便就未来的筹资提案开展合作。我们得到了NIHR临床研究网络在初级保健和老龄化方面的领导的支持，他们告诉我们，他们完全支持这项临床COP，因为它将促进关于规划未来研究的早期沟通。总体而言，这项临床COP旨在加快多发病研究的进展，同时确保它具有临床相关性，培训和激励临床医生工作，领导多发病研究，并规划对患者影响的路径。通过与关键合作伙伴合作，为更广泛的多发病研究社区开发一个可持续的在线平台，并制定未来的资助提案，这一临床COP遗产将比资助持续时间更长。

People tend to accumulate health problems and diagnoses. When several long-term health problems or diagnoses co-exist it is called multimorbidity. Our research is funded by the Strategic Priorities Fund as multimorbidity is now recognised as a huge problem in the UK and across the world. Traditionally, clinical research has focussed on one health condition, and often people with several diagnoses, or multimorbidity, have been excluded from research studies. We are asking for funding to work together between the research groups on multimorbidity. We aim to create a Community of Practice for clinicians (doctors, nurses, pharmacists, physiotherapists or from any clinical background) working on multimorbidity research. This clinical "Community of Practice" (CoP) will provide an opportunity for clinicians researching multimorbidity in separate research groups to meet each other, learn, share ideas and come up with new ideas together to form future research.The clinical CoP will be focussed around an online platform, where we can interact with each other and form groups with specific focuses. For example, some health problems can be diagnosed without question - such as heart attack or stroke - while others are more complicated to define, such as mental health conditions, pain or incontinence. Even more complicated is linking different health problems into clusters. These smaller groups might focus on these complex areas. We will run a face-to-face launch event and work together to see what the priorities should be - we want to make sure that we work effectively to overcome the biggest challenges. After that, we will communicate with our members on the online platform (which we hope to develop with other clinical researchers in multimorbidity, via the National Institute of Health Research (NIHR)), on social media via a specific hashtag, and by a monthly newsletter. Our core group of investigators will meet every 3 months. 6 virtual workshops will be run on key topics. We will make sure that we talk to other funded CoPs to see if we can work together on specific topics to combine our clinical skills with their skills: for example with the proposed Statistical Methods CoP and Patient and Public Involvement and Engagement. We will conduct a survey via our networks to try to understand what clinicians think are the key priorities for multimorbidity research, which we will write up for publication and which is likely to lead on to other work in this area.The CoP will support the communication of this multimorbidity research to clinicians, and help to increase multimorbidity research and research delivery capacity. We will host symposiums, and already have agreement in principle from key partners in primary care and geriatric medicine to feature CoP research in their conferences. We will also host an event towards the end of the CoP funding as a clinical showcase to a wider clinical audience and other interested people. A further key way in which the clinical CoP can support multimorbidity work is to consider the next steps in this research and how we can move towards patient benefit. We anticipate that this will be the focus of a working group, a virtual workshop and a writing group to work together on future funding proposals. We have the support of the NIHR Clinical Research Network leads in Primary Care and Ageing, who have told us that they fully support this clinical CoP as it will facilitate early communication about planning future research.Overall, this clinical CoP aims to accelerate progress in multimorbidity research, while ensuring that it is clinically relevant, train and enthuse clinicians to work and lead multimorbidity research and plan pathways to patient impact. By working with key partners, developing a sustainable online platform for the wider multimorbidity research community and development of future funding proposals this clinical CoP legacy will outlast the funding.